Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 21, 2023 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 667 | $8.65 | 114,595 | |
| Jul 20, 2023 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 359 | $8.74 | 47,904 | |
| Jul 20, 2023 | SVP/GM, VIT | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 333 | $8.74 | 58,383 | |
| Jul 20, 2023 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,982 | $8.74 | 532,438 | |
| Jul 20, 2023 | SVP Global Operations and R&D | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 332 | $8.74 | 28,654 | |
| Jul 20, 2023 | SVP International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 616 | $8.74 | 19,506 | |
| Jul 20, 2023 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 717 | $8.74 | 115,262 | |
| Jul 19, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,041 | -- | 66,502 | |
| Jul 19, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,041 | -- | 17,041 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,384 | -- | 48,263 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.